Shimadzu’s new ASAPrep for RPC
Shimadzu?s new ASAPrep for RPC (?Automated Scale-up from Analytical to Preparative conditions for Reversed Phase Purification?) predicts success and failure of purification automatically and determines an optimal preparative condition.f
Breakthrough in purification
The quality of purification processes in, e.g. medicinal chemistry, has been highly dependent on the chromatographers’ skill. Large pharmaceutical companies are capable of synthesizing hundreds of new compounds per day, but they cannot provide high purity compounds in sufficient amounts for High Throughput Screening (HTS), nor does the speed of purification match NCE (New Chemical Entities) synthesis.
Shimadzu’s new ASAPrep for RPC (“Automated Scale-up from Analytical to Preparative conditions for Reversed Phase Purification”) predicts success and failure of purification automatically and determines an optimal preparative condition. Based on an algorithm, the preparative method is created automatically, and users save time while increasing throughput. The algorithm calculates optimal initial organic mobile phase concentration in preparative scale using the retention time acquired by LC-PDA-MS measurement and judging of the difference between success and failure of purification.
ASAPrep for RPC runs on an LCMS-2010 single quadrupole system in analytical and preparative mode.
For more information please visit www.shimadzu.eu
Diving Deep into Carrier-Based Formulation and Process Optimization
December 23rd 2024Carrier-based formulations for dry powder inhalers are carefully designed to transport extremely small particles into the lungs. Jet milling can be used to micronize these particles, with both high and low shear mixing processes used to formulate mixtures capable of carrying the fine API particles into the deep lung. This paper looks at the requirements for pulmonary delivery via carrier-based inhaled powder formulations, and how jet milling can be used to manufacture effective and stable materials for these formulations
Molecular Properties of PROTACs and the Relationship to Formulation Design
December 20th 2024Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
